Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background/aim</h3><p>Emerging studies have revealed the mechanism of microRNAs (miRNAs) in acute kidney injury (AKI). However, almost no research focuses on miR-183-3p in AKI. Therefore, this study is started to explore the potential role of miR-183-3p from the perspective of Sirtuin (SIRT1)/forkhead box O3a (FOXO3a)/p53 up-regulated modulator of apoptosis (PUMA) in AKI.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>AKI rat models were established. miR-183-3p, SIRT1, deacetylated FOXO3a and PUMA expression in AKI were detected. The targeting relationship between miR-183-3p and SIRT1 was tested. AKI modeled rats were injected with miR-183-3p- or SIRT1-related sequences to identify their effects on AKI. Rat renal tubular epithelial cells NRK-52E were transfected with miR-183-3p- or SIRT1-related sequences for further exploration of their roles in vitro.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Decreased SIRT1 and deacetylated FOXO3a and increased miR-183-3p and PUMA were found in AKI. SIRT1 was targeted by miR-183-3p. Down-regulated miR-183-3p or up-regulated SIRT1 attenuated renal tissue damage and fibrosis, and suppressed renal tubular epithelial cell apoptosis in renal tissues of AKI rats. Down-regulated miR-183-3p or up-regulated SIRT1 promoted proliferation and impaired fibrosis and apoptosis of renal tubular epithelial cells.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Our study provides evidence that down-regulated miR-183-3p or up-regulated SIRT1 attenuates AKI via PUMA inhibition induced by FOXO3a deacetylation. Thus, miR-183-3p and SIRT1 can be the candidates for therapy of AKI.</p>

What problem does this paper attempt to address?

The problem this paper attempts to address is to explore the mechanism of action of microRNA-183-3p (miR-183-3p) in acute kidney injury (AKI), particularly through the Sirtuin 1 (SIRT1), p53 upregulated modulator of apoptosis (PUMA), and Forkhead box protein O3a (FOXO3a) axis. Specifically, the researchers aim to improve tubulointerstitial fibrosis (TIF) after AKI by downregulating miR-183-3p or upregulating SIRT1, and to reduce apoptosis by inhibiting the deacetylation of FOXO3a and the expression of PUMA. ### Background and Objectives - **Background**: Acute kidney injury (AKI) is a disease characterized by a rapid loss of renal excretory function, mainly caused by factors such as hemorrhage, septic shock, infection, drug toxicity, and postoperative complications. Tubulointerstitial fibrosis (TIF) is the final pathway of chronic kidney disease, and the incidence and mortality of AKI are increasing year by year, necessitating the development of new therapeutic approaches. - **Objectives**: To investigate the mechanism of action of miR-183-3p in AKI, particularly through the SIRT1/PUMA/FOXO3a axis, with the aim of providing new targets for the treatment of AKI. ### Methods - **Animal Model**: An AKI rat model was established, and the expression of miR-183-3p, SIRT1, deacetylated FOXO3a, and PUMA was detected. - **Experimental Design**: By injecting miR-183-3p inhibitors or SIRT1-related sequences, the effects of these treatments on renal tissue damage and fibrosis in AKI rats were observed. In addition, in vitro experiments were conducted by transfecting NRK-52E renal tubular epithelial cells with miR-183-3p or SIRT1-related sequences to further validate their roles. ### Results - **Expression Changes**: In AKI rats, the expression of miR-183-3p increased, the expression of SIRT1 and deacetylated FOXO3a decreased, and the expression of PUMA increased. - **Functional Validation**: Downregulation of miR-183-3p or upregulation of SIRT1 can alleviate renal tissue damage and fibrosis and inhibit apoptosis of renal tubular epithelial cells. - **Molecular Mechanism**: miR-183-3p targets SIRT1, affecting the deacetylation of FOXO3a and the expression of PUMA, thereby regulating apoptosis and fibrosis. ### Conclusion - **Main Findings**: Downregulation of miR-183-3p or upregulation of SIRT1 can improve tubulointerstitial fibrosis after AKI by inhibiting the expression of PUMA and reducing the deacetylation of FOXO3a. - **Potential Applications**: miR-183-3p and SIRT1 may be new targets for the treatment of AKI. In summary, this study provides new insights into the mechanism of action of miR-183-3p in AKI and offers a theoretical basis for the development of new therapeutic strategies.

Depleting microRNA-183-3p improves renal tubulointerstitial fibrosis after acute kidney injury via SIRT1/PUMA/FOXO3a deacetylation

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

MicroRNA-216a-5p Alleviates Acute Kidney Injury of Mice via Suppressing FAS Ligand Expression

Knockdown of Mir-214 Alleviates Renal Interstitial Fibrosis by Targeting the Regulation of the PTEN/PI3K/AKT Signalling Pathway

Supplementary Material For: Mir-874-3p is Identified As a Biomarker for Acute Kidney Injury and Mediates Disease Development Via Targeting MSRB3

miR-874-3p Is Identified as a Biomarker for Acute Kidney Injury and Mediates Disease Development via Targeting MSRB3

SIRT3 mediates mitofusin 2 ubiquitination and degradation to suppress ischemia reperfusion-induced acute kidney injury

Downregulation of mmu_circ_0000943 ameliorates renal ischemia reperfusion-triggered inflammation and oxidative stress via regulating mmu-miR-377-3p/Egr2 axis

microRNA-216a-5p alleviates acute kidney injury of mice via suppressing FASL expression

MiR-155 is Involved in Renal Ischemia-Reperfusion Injury via Direct Targeting of FoxO3a and Regulating Renal Tubular Cell Pyroptosis.

SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model

MicroRNA-874-3p/ADAM (A Disintegrin and Metalloprotease) 19 Mediates Macrophage Activation and Renal Fibrosis After Acute Kidney Injury

Expressions and related mechanisms of miR-212 and KLF4 in rats with acute kidney injury

SIRT7 silencing by miR-152-3p confers cell apoptosis and renal functional impairment induced by renal ischaemia/reperfusion injury

SIRT3 deficiency exacerbates early-stage fibrosis after ischaemia-reperfusion-induced AKI

Mir-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1

AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury

Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs

miR-195-5p alleviates acute kidney injury through repression of inflammation and oxidative stress by targeting vascular endothelial growth factor A

Downregulating ANGPTL3 by Mir-144-3p Promoted TGF-81-induced Renal Interstitial Fibrosis Via Activating PI3K/AKT Signaling Pathway